Back to Search Start Over

Five-Year Follow-Up of Bilateral Epidural Prefrontal Cortical Stimulation for Treatment-Resistant Depression.

Five-Year Follow-Up of Bilateral Epidural Prefrontal Cortical Stimulation for Treatment-Resistant Depression.

Authors :
Williams, Nolan R.
Short, E. Baron
Hopkins, Thomas
Bentzley, Brandon S.
Sahlem, Greg L.
Pannu, Jaspreet
Schmidt, Matt
Borckardt, Jeff J.
Korte, Jeffrey E.
George, Mark S.
Takacs, Istvan
Nahas, Ziad
Source :
Brain Stimulation; Nov2016, Vol. 9 Issue 6, p897-904, 8p
Publication Year :
2016

Abstract

Background Epidural prefrontal cortical stimulation (EpCS) represents a novel therapeutic approach with many unique benefits that can be used for treatment-resistant depression (TRD). Objective To examine the long-term safety and efficacy of EpCS of the frontopolar cortex (FPC) and dorsolateral prefrontal cortex (DLPFC) for treatment of TRD. Methods Adults ( N  = 5) who were 21–80 years old with severe TRD [failure to respond to adequate courses of at least 4 antidepressant medications, psychotherapy and ≥20 on the Hamilton Rating Scale for Depression (HRSD24)] were recruited. Participants were implanted with bilateral EpCS over the FPC and DLPFC and received constant, chronic stimulation throughout the five years with Medtronic IPGs. They were followed for 5 years (2/1/2008–10/14/2013). Efficacy of EpCS was assessed with the HRSD24 in an open-label design as the primary outcome measure at five years. Results All 5 patients continued to tolerate the therapy. The mean improvements from pre-implant baseline on the HRSD24 were [7 months] 54.9% (±37.7), [1 year] 41.2% (±36.6), [2 years] 53.8% (±21.7), and [5 years] 45% (±47). Three of 5 (60%) subjects continued to be in remission at 5 years. There were 5 serious adverse events: 1 electrode ‘paddle’ infection and 4 device malfunctions, all resulting in suicidal ideation and/or hospitalization. Conclusion These results suggest that chronic bilateral EpCS over the FPC and DLPFC is a promising and potentially durable new technology for treating TRD, both acutely and over 5 years. [ABSTRACT FROM AUTHOR]

Details

Language :
English
ISSN :
1935861X
Volume :
9
Issue :
6
Database :
Supplemental Index
Journal :
Brain Stimulation
Publication Type :
Academic Journal
Accession number :
119158723
Full Text :
https://doi.org/10.1016/j.brs.2016.06.054